BFR Training on Muscle Morphology

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-35
SponsorUdayana University

About this trial

This randomized clinical trial study compares high-load eccentric training (HL-Et), sham LL-BFRt, and low-load blood flow restriction (LL-BFRt) in sportsmen. The primary inquiries it seeks to address are:

Is LL-BFR superior to HL-Et and sham LL-BFRt in terms of improving muscle morphology? Is LL-BFR a more effective Patellofemoral Pain Syndrome and ACL injury preventive than HL-Et and sham LL-BFRt?

The three intervention groups that will be randomly assigned to participants are LL-BFRt, sham LL-BFRt, and HL-Et. Participants are expected to carry out:

Participants in LL-BFRt will be required to perform LL eccentric training at 30% of their repetition maximum (RM) and 70% of their artery occlusion pressure (AOP). This training will include stairs, single leg squat, and single leg deadlift.

Participants in HL-Et will be required to perform LL eccentric training at 70% of their maximum number of repetitions (RM).

In order to determine whether muscular morphology and the prevention of Patellofemoral Pain Syndrome and ACL injury improve following the interventions and follow-up, researchers will compare LL-BFRt, sham LL-BFRt, and HL-Et.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Being between the ages of 15 and 35

Play level 1 sports (fight martial arts, basketball, futsal, and soccer) at least twice a week

Never experienced an Patellofemoral Pain Syndrome or ACL injury before

Never experienced a grade III sprain or strain

Disqualifiers

Having a tumor, cancer, vena thromboembolic disease, obesity, diabetes, hypertension, anemia, and renal failure

Disabilities or those who are disabled.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Low load-BFRt

    Procedure/Surgery

    The participants' two legs will be subjected to 70% arterial occlusion pressure when the physical therapist applies the BFR cuffs. After that, participants will be required to complete eccentric exercises with a maximum repetition count of 30%, such as stairs, single leg squat, and single leg deadlift.

  • Sham Low load-BFRt

    Procedure/Surgery

    The participants' two legs will be subjected to 10% arterial occlusion pressure when the physical therapist applies the BFR cuffs. After that, participants will be required to complete eccentric exercises with a maximum repetition count of 30%, such as stairs, single leg squat, and single leg deadlift.

  • High load-Eccentric training

    Procedure/Surgery

    The physical therapist will instruct the participants to complete eccentric exercises at a maximum of 70% repetitions, such as stairs, single leg squat, and single leg deadlift.

Treatment groups

75 Participants
are divided into 3 treatment groups
Group A: Low load-BFRtExperimental treatment 1 intervention
Group B: Sham Low load-BFRtSham comparator 1 intervention
Group C: High load-Eccentric trainingActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Muscle cross-sectional area

Using a musculoskeletal ultrasonography, researchers will determine the cross-sectional area of vastus medial obliques muscle and peroneus longus muscle.

Time frame
8 weeks
2

Vastus medial obliques fiber angle

Using a musculoskeletal ultrasonography, researchers will determine the vastus medial obliques fiber angle.

Time frame
8 weeks
3

Patella position

Using a musculoskeletal ultrasonography, researchers will determine the patella position.

Time frame
8 weeks

Secondary outcomes

1

Incidence of patellofemoral pain syndrome

Researchers will determine the incidence of patellofemoral pain syndrome with the physical examination of grind test.

Time frame
1 year
2

Incidence of anterior cruciate ligament injury

Researchers will determine the incidence of anterior cruciate ligament injury with the physical examination of Lachman's test.

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.